Primary Venture Partners raises $625M Fund V, betting on seed as mega platforms overextend downmarket

Summary

Primary Venture Partners closes $625M Fund V

Brad Svrluga, co-founder and General Partner at Primary Venture Partners, has closed $625M for the firm's fifth family of funds. The raise comprises a pure seed fund and a "select fund" that doubles down on the firm's portfolio breakouts. The firm's model, which Svrluga and co-founder Ben Sun built from the start a decade ago, is institutional seed at scale.

The competitive setup

The thesis behind staying seed-focused is essentially a bet against the mega-platforms. Svrluga says every competitive seed deal now has at least one large multistage firm "around the hoop," and he's seen three full cycles of big firms moving downmarket in his career. His read is that founders eventually figure out the trade-off: some of those platforms openly say they'll seed multiple competitors in a category and back the winner later. Rational for the fund, not ideal if you're a seed-stage founder looking for a committed lead.

What Primary is looking for now

On the product side, Svrluga argues that vibe coding and fast prototyping compress the timeline to an impressive demo but don't substitute for domain knowledge. Legal tech is his clearest example: the breakout companies in that space all have lawyers among their founders, and that pattern holds across verticals. Character and grit in the founding team, he says, remains the variable that actually drives outcomes.

Two areas where Primary is leaning in more actively:

• Crypto and blockchain: Svrluga says the firm has been light here for several years but the application layer is starting to look more interesting, led by partner Emily on the financial services side.
• AI and biology: Partner Sam Toole leads the healthcare practice, and Primary has recently brought on a venture partner to explore companies at the intersection of AI and life sciences. Svrluga's framing is that the most important life sciences companies of the next decade will look more like computer science companies than traditional biotech.

The SaaS pricing question

Svrluga is direct that seat-based SaaS pricing is in trouble, but also honest that nobody knows what replaces it. His position is that usage-based or value-based models are the direction of travel, the transition is happening week to week, and anyone claiming certainty right now is wrong. The premium Primary puts on founders who can adapt quickly is higher than it's ever been.

The opportunity he keeps returning to is software bundled with completed work, not just tools. His portfolio company Lighttable, which operates in architecture and engineering design, takes a quality-control process that previously took three months and does it in thirty minutes. Svrluga says that "software plus the work itself" model is what legal tech has figured out and what will play across many sectors.

The IPO pipeline and liquidity

Primary's LPs are starved for liquidity in a year when the asset class has not consistently returned more than it's raised. Svrluga expects the anticipated IPOs from OpenAI, Anthropic, and SpaceX to help unlock capital, but he flags that much of the near-term IPO pipeline is traditional seat-based SaaS companies in a "weird limbo" right now. He's not certain those headline exits automatically produce a tidal wave of downstream activity.

New York versus the Bay

Primary now does equal work on both coasts despite its New York roots. Svrluga's view is that the current AI cycle is foundational and infrastructure-driven, which is a Bay Area phase. When the cycle shifts toward go-to-market, enterprise accounts, and customer proximity, New York's advantages in financial services, media, and consumer industries come back into focus. The two-coast presence is deliberate, not incidental.